Elevated RHAMM as a biomarker for predicting diabetic kidney disease in patients with type 2 diabetesBingxue Qi(People 's Hospital of Jilin Province), Li-Hao Huang(Fudan University)Clinical Kidney JournalJuly 1, 202410.1093/ckj/sfae196Cited by 2SaveCiteExport RISWatch citationsRelated PapersO‐linked β‐N‐acetylglucosamine (O‐<scp>GlcNAc</scp>) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy|Diabetic Medicine|2024|19